triazoles has been researched along with salmeterol xinafoate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axelrod, S; Bielory, L | 1 |
Burrows, J; Clarke, N; Feeder, N; Glossop, P; James, K; Jones, LH; Jones, RM; Kenyon, AS; Patel, S; Roberts, DF; Selby, MD; Strang, RS; Stuart, EF; Trevethick, MA; Watson, J; Wright, KN | 1 |
2 other study(ies) available for triazoles and salmeterol xinafoate
Article | Year |
---|---|
Beta2-agonists and paresthesias in multiple sclerosis.
Topics: Adrenergic beta-Agonists; Albuterol; Amantadine; Analgesics, Non-Narcotic; Androstadienes; Aromatase Inhibitors; Asthma; Bronchodilator Agents; Donepezil; Drug Therapy, Combination; Female; Fluticasone; Food Hypersensitivity; Humans; Indans; Interferons; Latex Hypersensitivity; Letrozole; Mandelic Acids; Middle Aged; Multiple Sclerosis; Nebulizers and Vaporizers; Nitriles; Nootropic Agents; Parasympatholytics; Paresthesia; Piperidines; Respiratory Function Tests; Salmeterol Xinafoate; Thyroxine; Triazoles | 2007 |
Molecular hybridization yields triazole bronchodilators for the treatment of COPD.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Biological Availability; Bronchoconstriction; Bronchodilator Agents; CHO Cells; Cricetulus; Dogs; Humans; Ipratropium; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Rats; Receptor, Muscarinic M3; Salmeterol Xinafoate; Tiotropium Bromide; Triazoles | 2015 |